Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Amfebutamone for second-line treatment only

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Amfebutamone for second-line treatment only. React. Wkly. 873, 2 (2001). https://doi.org/10.2165/00128415-200108730-00001

    Download citation


    • Nicotine
    • Smoking Cessation
    • Bupropion
    • Bulimia Nervosa
    • Nicotine Replacement Therapy